Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.11 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.64.
Market Cap
9.11T
Revenue
4.67T
Profits
191.22B
PE Ratio
47.64
Profit Margin
4.10%
Dividend Yield
0.39%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | 0.02% | 1,978,925 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 609.54B | -1.21% | 10,032,740 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 469.63B | 1.12% | 7,544,505 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 344.27B | -3.30% | 9,485,736 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 339.81B | 1.80% | 5,828,920 | 450.53B |
| 6 | NVS | Novartis AG | 266.38B | -0.05% | 1,329,232 | 56.69B |
| 7 | TMO | Thermo Fisher Scientific Inc. | 250.23B | 3.35% | 2,124,657 | 46.34B |
| 8 | AZN | AstraZeneca PLC | 241.24B | -0.24% | 2,256,366 | 61.37B |
| 9 | AMGN | Amgen Inc. | 217.86B | -0.01% | 3,104,125 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 179.33B | -0.08% | 6,138,328 | 30.46B |
| 11 | ABT | Abbott Laboratories | 173.21B | 2.67% | 11,988,858 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 163.75B | 0.59% | 18,700,718 | 50.34B |
| 13 | PFE | Pfizer Inc. | 156.23B | -1.40% | 33,005,432 | 63.70B |
| 14 | DHR | Danaher Corporation | 155.51B | 3.34% | 3,093,907 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 143.60B | 3.71% | 1,664,638 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 127.62B | -0.24% | 915,135 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.13B | -3.83% | 19,239,536 | 49.19B |
| 18 | MDT | Medtronic plc | 112.53B | 1.84% | 43,694,399 | 37.54B |
| 19 | CVS | CVS Health Corporation | 111.28B | 0.64% | 12,009,985 | 412.65B |
| 20 | SYK | Stryker Corporation | 109.40B | 3.55% | 3,331,598 | 25.84B |
| 21 | MCK | McKesson Corporation | 106.73B | 1.46% | 697,632 | 410.98B |
| 22 | HCA | HCA Healthcare, Inc. | 94.16B | 1.93% | 1,148,873 | 78.01B |
| 23 | SNY | Sanofi | 93.99B | -1.03% | 3,798,144 | 55.89B |
| 24 | GSK | GSK plc | 93.19B | -1.02% | 3,480,791 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 85.56B | 2.09% | 712,110 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 81.13B | 6.95% | 19,313,307 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 72.54B | -1.19% | 695,028 | 15.53B |
| 28 | CI | The Cigna Group | 71.69B | 0.28% | 1,536,157 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 61.45B | -0.47% | 13,744,303 | 21.00B |
| 30 | NTRA | Natera, Inc. | 61.35B | 3.73% | 2,021,832 | 2.71B |
| 31 | COR | Cencora, Inc. | 60.10B | 1.90% | 1,148,053 | 332.77B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 56.99B | -0.28% | 3,404,593 | 28.42B |
| 33 | ARGX | argenx SE | 56.95B | -0.69% | 322,128 | 5.32B |
| 34 | CAH | Cardinal Health, Inc. | 53.98B | 2.11% | 1,721,815 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 50.28B | 2.44% | 3,315,849 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.21B | 2.19% | 1,644,969 | 22.48B |
| 37 | HUM | Humana Inc. | 48.52B | 4.05% | 1,518,942 | 145.68B |
| 38 | A | Agilent Technologies, Inc. | 48.29B | 2.09% | 1,768,932 | 7.37B |
| 39 | MDLN | Medline Inc. | 47.07B | 0.53% | 10,614,937 | 29.94B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 46.22B | 0.33% | 4,147,902 | 17.32B |
| 41 | VEEV | Veeva Systems Inc. | 45.89B | 3.70% | 1,324,857 | 3.46B |
| 42 | RVMD | Revolution Medicines, Inc. | 44.51B | 0.50% | 1,424,725 | - |
| 43 | ILMN | Illumina, Inc. | 44.35B | 7.56% | 4,222,943 | 4.49B |
| 44 | IQV | IQVIA Holdings Inc. | 43.80B | 3.05% | 1,688,071 | 16.98B |
| 45 | WAT | Waters Corporation | 43.24B | 3.51% | 1,007,436 | 4.64B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 41.52B | 1.67% | 588,919 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 41.12B | 1.00% | 392,122 | 6.13B |
| 48 | HLN | Haleon plc | 38.53B | 0.23% | 11,866,756 | 14.80B |
| 49 | BIIB | Biogen Inc. | 33.04B | 1.69% | 951,321 | 10.03B |
| 50 | DXCM | DexCom, Inc. | 32.79B | 1.80% | 3,079,141 | 4.97B |
| 51 | RPRX | Royalty Pharma plc | 32.58B | -0.87% | 3,958,018 | 2.54B |
| 52 | CNC | Centene Corporation | 31.76B | 2.08% | 4,538,948 | 180.30B |
| 53 | RMD | ResMed Inc. | 31.34B | 1.81% | 976,464 | 5.65B |
| 54 | MTD | Mettler-Toledo International Inc. | 30.89B | 3.73% | 167,811 | 4.13B |
| 55 | ALC | Alcon Inc. | 30.87B | 0.89% | 1,375,908 | 10.86B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 29.69B | 2.26% | 4,299,792 | 21.27B |
| 57 | ZTS | Zoetis Inc. | 29.51B | 2.47% | 3,644,366 | 9.53B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.42B | 0.08% | 1,281,105 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.51B | 3.23% | 682,772 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.84B | 0.17% | 6,201,635 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 25.63B | -0.48% | 1,014,262 | 11.56B |
| 62 | GH | Guardant Health, Inc. | 25.12B | 5.30% | 1,746,285 | 1.18B |
| 63 | LH | Labcorp Holdings Inc. | 25.03B | 0.05% | 705,912 | 14.35B |
| 64 | BNTX | BioNTech SE | 24.53B | 0.76% | 1,437,531 | 3.03B |
| 65 | PHG | Koninklijke Philips N.V. | 23.28B | -0.04% | 1,161,546 | 20.18B |
| 66 | INCY | Incyte Corporation | 23.13B | -1.01% | 1,948,759 | 5.82B |
| 67 | UTHR | United Therapeutics Corporation | 23.01B | -0.98% | 833,723 | 3.15B |
| 68 | INSM | Insmed Incorporated | 22.67B | -6.56% | 5,395,744 | 1.14B |
| 69 | GMAB | Genmab A/S | 21.31B | 10.73% | 12,403,391 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 20.89B | 0.33% | 693,028 | 21.81B |
| 71 | STE | STERIS plc | 20.58B | 1.21% | 804,060 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.24B | 0.11% | 6,356,832 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 17.56B | 3.85% | 1,551,387 | 2.91B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 17.47B | 3.72% | 2,293,176 | 8.51B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.32B | 3.51% | 341,180 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.32B | 0.16% | 844,580 | 4.60B |
| 77 | TEM | Tempus AI, Inc. | 15.08B | 9.03% | 7,273,894 | 1.43B |
| 78 | SOLV | Solventum Corporation | 14.98B | 0.20% | 1,044,022 | 8.31B |
| 79 | ASND | Ascendis Pharma A/S | 14.98B | 0.07% | 783,227 | 1.20B |
| 80 | CRL | Charles River Laboratories International, Inc. | 14.84B | 7.09% | 1,305,696 | 4.00B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 14.66B | 0.72% | 1,748,234 | 3.37B |
| 82 | EXEL | Exelixis, Inc. | 14.58B | 0.79% | 2,580,702 | 2.44B |
| 83 | SMMT | Summit Therapeutics Inc. | 13.78B | 3.07% | 5,277,705 | - |
| 84 | CORT | Corcept Therapeutics Incorporated | 13.19B | 4.99% | 1,004,939 | 830.81M |
| 85 | ICLR | ICON Public Limited Company | 12.99B | 3.88% | 932,547 | 8.29B |
| 86 | BBIO | BridgeBio Pharma, Inc. | 12.93B | -1.65% | 2,168,568 | 713.07M |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.92B | 2.90% | 3,401,293 | 14.37B |
| 88 | TWST | Twist Bioscience Corporation | 12.86B | 8.66% | 3,207,966 | 431.80M |
| 89 | TXG | 10x Genomics, Inc. | 12.73B | 4.53% | 3,100,559 | 616.91M |
| 90 | BAX | Baxter International Inc. | 12.52B | 3.11% | 10,163,191 | 11.47B |
| 91 | PEN | Penumbra, Inc. | 12.49B | -0.14% | 368,274 | 1.50B |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.29B | -1.41% | 1,856,187 | 1.66B |
| 93 | FMS | Fresenius Medical Care AG | 11.96B | 1.80% | 567,519 | 22.19B |
| 94 | EHC | Encompass Health Corporation | 11.93B | 0.98% | 1,061,641 | 6.21B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.40B | -1.16% | 246,484 | 1.28B |
| 96 | DVA | DaVita Inc. | 11.40B | 0.02% | 452,017 | 14.01B |
| 97 | TECH | Bio-Techne Corporation | 11.38B | 0.25% | 2,087,229 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.25B | 1.67% | 4,788,213 | 5.02B |
| 99 | SNN | Smith & Nephew plc | 11.17B | 1.89% | 1,874,095 | 6.30B |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 11.14B | 0.63% | 2,407,511 | 3.41B |
| 101 | IBRX | ImmunityBio, Inc. | 11.00B | 0.92% | 16,866,948 | 165.79M |
| 102 | PCVX | Vaxcyte, Inc. | 10.98B | 30.70% | 14,924,050 | - |
| 103 | COO | The Cooper Companies, Inc. | 10.80B | -0.25% | 3,948,587 | 4.24B |
| 104 | RGEN | Repligen Corporation | 10.69B | 4.29% | 1,613,627 | 785.10M |
| 105 | AVTR | Avantor, Inc. | 10.69B | 3.06% | 8,180,402 | 6.56B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.45B | 0.57% | 2,744,204 | 3.50B |
| 107 | UHS | Universal Health Services, Inc. | 10.38B | 0.19% | 580,149 | 18.11B |
| 108 | GMED | Globus Medical, Inc. | 10.28B | 1.28% | 1,606,799 | 3.14B |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.16B | 2.89% | 279,403 | 2.59B |
| 110 | MOH | Molina Healthcare, Inc. | 10.11B | 2.38% | 903,770 | 42.47B |
| 111 | OSCR | Oscar Health, Inc. | 10.00B | 4.78% | 4,683,654 | 15.32B |
| 112 | ALGN | Align Technology, Inc. | 9.99B | -2.15% | 1,680,197 | 4.14B |
| 113 | ENSG | The Ensign Group, Inc. | 9.99B | 0.65% | 476,542 | 5.49B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.91B | 3.90% | 337,046 | 440.48M |
| 115 | BRKR | Bruker Corporation | 9.73B | 0.98% | 2,016,476 | 3.50B |
| 116 | GKOS | Glaukos Corporation | 9.67B | 0.16% | 837,810 | 612.84M |
| 117 | QGEN | Qiagen N.V. | 9.47B | 2.32% | 3,054,758 | 2.10B |
| 118 | PODD | Insulet Corporation | 9.41B | 2.98% | 1,940,341 | 3.05B |
| 119 | HSIC | Henry Schein, Inc. | 9.39B | -0.77% | 1,904,339 | 13.60B |
| 120 | AXSM | Axsome Therapeutics, Inc. | 9.28B | -1.21% | 858,894 | 776.57M |
| 121 | KYMR | Kymera Therapeutics, Inc. | 9.13B | 2.29% | 729,726 | 105.00M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.10B | 0.41% | 1,273,823 | 281.99M |
| 123 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.81B | -2.87% | 2,249,456 | 669.50M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.72B | -4.42% | 3,234,412 | 67.67M |
| 125 | CAI | Caris Life Sciences, Inc. | 8.59B | 7.39% | 4,959,323 | 989.61M |
| 126 | SYRE | Spyre Therapeutics, Inc. | 8.18B | -0.50% | 642,857 | - |
| 127 | HNGE | Hinge Health, Inc. | 7.94B | 0.70% | 3,175,276 | 720.06M |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 7.92B | -4.04% | 511,236 | 7.46M |
| 129 | ABVX | ABIVAX Société Anonyme | 7.91B | -1.24% | 840,305 | 5.33M |
| 130 | ATR | AptarGroup, Inc. | 7.67B | 0.58% | 413,132 | 3.93B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.65B | -0.70% | 1,546,886 | 799.54M |
| 132 | HQY | HealthEquity, Inc. | 7.57B | 1.68% | 1,017,925 | 1.36B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.23B | -0.09% | 2,871,833 | 874.09M |
| 134 | ALKS | Alkermes plc | 7.17B | 2.42% | 3,125,273 | 1.67B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.09B | 0.25% | 3,909,040 | 3.12B |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.92B | 2.31% | 7,996,556 | 2.58B |
| 137 | GRAL | GRAIL, Inc. | 6.88B | 7.55% | 1,472,205 | 165.26M |
| 138 | IMVT | Immunovant, Inc. | 6.87B | -1.10% | 1,104,070 | - |
| 139 | PACS | PACS Group, Inc. | 6.76B | -0.33% | 844,533 | 5.55B |
| 140 | CHE | Chemed Corporation | 6.65B | 0.75% | 139,768 | 2.60B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.54B | 0.23% | 658,891 | 1.56B |
| 142 | GRFS | Grifols, S.A. | 6.49B | 1.37% | 492,766 | 8.48B |
| 143 | BLTE | Belite Bio, Inc | 6.41B | -0.24% | 133,266 | - |
| 144 | IOVA | Iovance Biotherapeutics, Inc. | 6.41B | -0.49% | 11,751,492 | 324.97M |
| 145 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.37B | -0.41% | 1,027,247 | 239.92M |
| 146 | BLCO | Bausch + Lomb Corporation | 6.13B | 0.35% | 402,798 | 5.32B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.12B | 1.26% | 163,820 | 290.54M |
| 148 | CGON | CG Oncology, Inc. | 6.09B | 1.97% | 788,354 | 6.23M |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.95B | 0.69% | 391,512 | 840.85M |
| 150 | KOD | Kodiak Sciences Inc. | 5.88B | -0.68% | 3,235,663 | - |
| 151 | MMED | MiniMed Group, Inc. | 5.67B | 2.34% | 15,348,320 | 3.22B |
| 152 | ORKA | Oruka Therapeutics, Inc. | 5.59B | -0.17% | 629,593 | - |
| 153 | RDNT | RadNet, Inc. | 5.55B | 0.92% | 681,368 | 2.27B |
| 154 | CRSP | CRISPR Therapeutics AG | 5.54B | 3.45% | 1,703,095 | 13.39M |
| 155 | STVN | Stevanato Group S.p.A. | 5.48B | -0.74% | 652,581 | 1.40B |
| 156 | TVTX | Travere Therapeutics, Inc. | 5.44B | 1.30% | 2,643,947 | 591.33M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.36B | -0.48% | 1,792,883 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.31B | 0.30% | 1,044,026 | 1.01B |
| 159 | TFX | Teleflex Incorporated | 5.31B | 0.90% | 561,639 | 2.25B |
| 160 | SHC | Sotera Health Company | 5.29B | 1.81% | 2,505,983 | 1.22B |
| 161 | MIRM | Mirum Pharmaceuticals, Inc. | 5.29B | -1.81% | 980,144 | 618.07M |
| 162 | SRRK | Scholar Rock Holding Corporation | 5.29B | -7.28% | 3,352,006 | - |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.20B | 2.07% | 699,158 | 1.58B |
| 164 | ERAS | Erasca, Inc. | 5.15B | -0.14% | 5,486,349 | - |
| 165 | BLLN | BillionToOne, Inc. | 5.15B | 2.98% | 407,796 | 397.41M |
| 166 | DOCS | Doximity, Inc. | 5.09B | 2.33% | 3,164,061 | 655.57M |
| 167 | WAY | Waystar Holding Corp. | 5.08B | 6.73% | 3,533,646 | 1.21B |
| 168 | MANE | Veradermics, Incorporated | 4.97B | 1.81% | 536,363 | - |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 4.92B | -0.19% | 597,421 | 1.90M |
| 170 | DFTX | Definium Therapeutics, Inc. | 4.87B | -3.13% | 2,602,204 | - |
| 171 | HAE | Haemonetics Corporation | 4.76B | - | 652,647 | 1.35B |
| 172 | ADPT | Adaptive Biotechnologies Corporation | 4.76B | 5.26% | 1,425,151 | 308.08M |
| 173 | LFST | LifeStance Health Group, Inc. | 4.67B | 3.30% | 3,232,274 | 1.58B |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.62B | 1.57% | 1,037,218 | 2.29B |
| 175 | HTFL | HeartFlow, Inc. | 4.54B | 5.86% | 2,453,179 | 212.07M |
| 176 | ABCL | AbCellera Biologics Inc. | 4.47B | 0.29% | 4,075,088 | 66.17M |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 4.38B | -2.66% | 1,633,799 | - |
| 178 | ITGR | Integer Holdings Corporation | 4.30B | - | 589,297 | 1.84B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.25B | 2.27% | 2,936,414 | 10.35M |
| 180 | INDV | Indivior Pharmaceuticals, Inc. | 4.25B | 0.78% | 3,003,291 | 1.33B |
| 181 | LIVN | LivaNova PLC | 4.21B | 1.81% | 558,948 | 1.47B |
| 182 | ICUI | ICU Medical, Inc. | 4.04B | 1.27% | 211,452 | 2.16B |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.89B | -0.69% | 1,943,939 | 53.81M |
| 184 | VCYT | Veracyte, Inc. | 3.83B | 4.06% | 1,289,129 | 561.90M |
| 185 | NVST | Envista Holdings Corporation | 3.75B | -0.51% | 2,701,925 | 2.86B |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.68B | 3.13% | 235,287 | 890.79M |
| 187 | IDYA | IDEAYA Biosciences, Inc. | 3.67B | 1.87% | 658,012 | 234.13M |
| 188 | PBLS | Parabilis Medicines, Inc. | 3.65B | -2.48% | 572,541 | 148.00K |
| 189 | XENE | Xenon Pharmaceuticals Inc. | 3.64B | -1.18% | 1,698,995 | 7.50M |
| 190 | LEGN | Legend Biotech Corporation | 3.64B | 1.10% | 1,763,284 | 1.27B |
| 191 | CDNA | CareDx, Inc. | 3.61B | 4.02% | 1,639,566 | 458.09M |
| 192 | NHC | National HealthCare Corporation | 3.61B | 1.19% | 112,691 | 1.56B |
| 193 | CELC | Celcuity Inc. | 3.60B | 2.11% | 1,718,387 | - |
| 194 | PLSE | Pulse Biosciences, Inc. | 3.60B | 5.43% | 433,452 | 1.19M |
| 195 | OGN | Organon & Co. | 3.60B | -0.15% | 2,881,740 | 6.13B |
| 196 | IRTC | iRhythm Holdings, Inc. | 3.60B | -1.16% | 626,268 | 825.34M |
| 197 | RGC | Regencell Bioscience Holdings Limited | 3.59B | 6.16% | 307,533 | - |
| 198 | OPCH | Option Care Health, Inc. | 3.50B | 3.22% | 2,822,889 | 5.69B |
| 199 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.49B | -0.04% | 941,081 | -665.00K |
| 200 | ACAD | Acadia Pharmaceuticals Inc. | 3.47B | 0.80% | 3,152,355 | 1.14B |
| 201 | VKTX | Viking Therapeutics, Inc. | 3.42B | -2.20% | 6,277,356 | - |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.33B | -3.19% | 821,505 | - |
| 203 | WRBY | Warby Parker Inc. | 3.29B | -1.41% | 3,034,723 | 911.61M |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | 1.99% | 939,607 | 606.33M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.18B | -0.45% | 1,717,655 | 3.60M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | -0.04% | 2,310,343 | 463.98M |
| 207 | RCUS | Arcus Biosciences, Inc. | 3.15B | 1.23% | 1,390,862 | 117.00M |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.88B | 1.58% | 4,377,364 | - |
| 209 | TMDX | TransMedics Group, Inc. | 2.88B | 4.00% | 995,113 | 668.47M |
| 210 | ZLAB | Zai Lab Limited | 2.88B | 5.30% | 787,360 | 449.61M |
| 211 | ATRC | AtriCure, Inc. | 2.87B | 2.23% | 1,095,536 | 569.62M |
| 212 | NEOG | Neogen Corporation | 2.84B | 7.08% | 5,151,796 | 870.40M |
| 213 | MBX | MBX Biosciences, Inc. | 2.82B | 0.05% | 583,214 | - |
| 214 | PGEN | Precigen, Inc. | 2.77B | -9.37% | 10,254,123 | 85.72M |
| 215 | NAMS | NewAmsterdam Pharma Company N.V. | 2.73B | -1.72% | 1,182,352 | 7.12M |
| 216 | AVAH | Aveanna Healthcare Holdings Inc. | 2.70B | -1.75% | 4,605,254 | 2.60B |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.69B | 2.89% | 2,431,130 | 3.37B |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.67B | -0.66% | 276,030 | 1.46B |
| 219 | ALMR | Alamar Biosciences, Inc. | 2.65B | 10.97% | 570,792 | 100.42M |
| 220 | PRVA | Privia Health Group, Inc. | 2.61B | 0.74% | 1,343,811 | 2.36B |
| 221 | BEAM | Beam Therapeutics Inc. | 2.57B | 4.78% | 2,001,780 | 156.04M |
| 222 | RXRX | Recursion Pharmaceuticals, Inc. | 2.56B | 16.02% | 67,278,675 | 54.86M |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.56B | 2.97% | 1,257,865 | 158.00K |
| 224 | BKD | Brookdale Senior Living Inc. | 2.51B | -3.04% | 4,402,020 | 2.93B |
| 225 | BFLY | Butterfly Network, Inc. | 2.50B | 4.80% | 5,234,201 | 112.14M |
| 226 | CLOV | Clover Health Investments, Corp. | 2.49B | 6.85% | 4,880,453 | 2.48B |
| 227 | SUPN | Supernus Pharmaceuticals, Inc. | 2.49B | 0.90% | 1,288,381 | 830.44M |
| 228 | LQDA | Liquidia Corporation | 2.47B | -3.49% | 7,759,906 | 450.91M |
| 229 | HCM | HUTCHMED (China) Limited | 2.46B | 0.77% | 65,114 | 549.12M |
| 230 | NEO | NeoGenomics, Inc. | 2.46B | 3.57% | 2,055,702 | 766.30M |
| 231 | SDGR | Schrödinger, Inc. | 2.44B | 7.56% | 4,619,289 | 259.04M |
| 232 | IRON | Disc Medicine, Inc. | 2.43B | -1.83% | 456,322 | - |
| 233 | IMNM | Immunome, Inc. | 2.40B | 1.29% | 1,216,227 | 4.02M |
| 234 | UFPT | UFP Technologies, Inc. | 2.38B | 2.20% | 134,951 | 631.64M |
| 235 | NRIX | Nurix Therapeutics, Inc. | 2.37B | -0.48% | 1,006,532 | 36.77M |
| 236 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | -0.94% | 4,514,190 | - |
| 237 | HRMY | Harmony Biosciences Holdings, Inc. | 2.32B | 0.71% | 897,920 | 959.90M |
| 238 | WGS | GeneDx Holdings Corp. | 2.27B | 4.35% | 855,224 | 454.43M |
| 239 | ADMA | ADMA Biologics, Inc. | 2.26B | 4.01% | 3,512,369 | 512.28M |
| 240 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.21B | 7.85% | 2,630,381 | 208.78M |
| 241 | BHC | Bausch Health Companies Inc. | 2.20B | 1.55% | 1,473,454 | 10.85B |
| 242 | AXGN | Axogen, Inc. | 2.18B | -0.45% | 2,186,489 | 251.17M |
| 243 | ALVO | Alvotech | 2.18B | 12.11% | 2,899,039 | 494.61M |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.16B | 0.75% | 604,389 | 1.10B |
| 245 | VRDN | Viridian Therapeutics, Inc. | 2.15B | -2.06% | 2,651,202 | 71.13M |
| 246 | VERA | Vera Therapeutics, Inc. | 2.15B | -1.94% | 2,715,140 | - |
| 247 | PHVS | Pharvaris N.V. | 2.14B | -2.24% | 816,234 | - |
| 248 | ADRX | ADARx Pharmaceuticals, Inc. | 2.13B | 4.38% | 913,953 | 6.13M |
| 249 | VCEL | Vericel Corporation | 2.10B | 2.29% | 648,584 | 306.30M |
| 250 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -0.69% | 802,893 | 311.51M |
| 251 | URGN | UroGen Pharma Ltd. | 2.09B | 3.33% | 1,276,526 | 188.73M |
| 252 | NVAX | Novavax, Inc. | 2.07B | 20.08% | 28,701,894 | 413.80M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.07B | 0.50% | 953,188 | 1.95B |
| 254 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.07B | -0.86% | 4,712,255 | 940.61M |
| 255 | ADUS | Addus HomeCare Corporation | 2.07B | 1.54% | 218,291 | 1.48B |
| 256 | MLYS | Mineralys Therapeutics, Inc. | 2.06B | -1.40% | 1,079,139 | - |
| 257 | TRLV | Trulieve Cannabis Corp. | 2.05B | -0.65% | 1,899,181 | 1.14B |
| 258 | INSP | Inspire Medical Systems, Inc. | 2.05B | 1.11% | 632,106 | 898.74M |
| 259 | FTRE | Fortrea Holdings Inc. | 2.01B | 5.55% | 2,266,623 | 2.68B |
| 260 | PRGO | Perrigo Company plc | 2.00B | 1.26% | 1,878,425 | 4.14B |
| 261 | VIR | Vir Biotechnology, Inc. | 1.99B | 5.46% | 3,147,232 | 303.23M |
| 262 | PGNY | Progyny, Inc. | 1.98B | 2.50% | 1,049,647 | 1.31B |
| 263 | ESTA | Establishment Labs Holdings Inc. | 1.98B | 3.76% | 392,120 | 245.82M |
| 264 | ABSI | Absci Corporation | 1.98B | 4.16% | 4,294,896 | 1.56M |
| 265 | GPCR | Structure Therapeutics Inc. | 1.97B | -0.29% | 1,868,289 | - |
| 266 | BHVN | Biohaven Ltd. | 1.96B | 0.78% | 1,671,734 | - |
| 267 | TRVI | Trevi Therapeutics, Inc. | 1.95B | -1.37% | 1,719,316 | - |
| 268 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 0.48% | 439,658 | 1.13B |
| 269 | XNCR | Xencor, Inc. | 1.91B | 3.18% | 1,276,618 | 104.97M |
| 270 | PVLA | Palvella Therapeutics, Inc. | 1.90B | -0.23% | 142,876 | - |
| 271 | BLFS | BioLife Solutions, Inc. | 1.89B | 3.51% | 4,445,979 | 106.69M |
| 272 | ASTH | Astrana Health, Inc. | 1.88B | 2.59% | 389,919 | 3.84B |
| 273 | AZTA | Azenta, Inc. | 1.87B | 10.27% | 2,370,512 | 613.81M |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 1.87B | -1.73% | 808,718 | 98.34M |
| 275 | ZYME | Zymeworks Inc. | 1.86B | 4.21% | 1,036,952 | 37.13M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 2.57% | 369,770 | 262.43M |
| 277 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -0.06% | 2,198,641 | 1.97B |
| 278 | XERS | Xeris Biopharma Holdings, Inc. | 1.85B | 11.56% | 4,664,810 | 335.41M |
| 279 | ZBIO | Zenas BioPharma, Inc. | 1.81B | -1.66% | 1,131,916 | 1.00M |
| 280 | FRNM | Freenome, Inc. | 1.81B | 3.12% | 772,774 | 35.41M |
| 281 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 4.00% | 4,967,541 | 59.51M |
| 282 | GENB | Generate Biomedicines, Inc. | 1.79B | 1.61% | 1,120,020 | 26.48M |
| 283 | MESO | Mesoblast Limited | 1.78B | 0.99% | 181,077 | 120.25M |
| 284 | NVCR | NovoCure Limited | 1.77B | 1.74% | 1,784,685 | 699.19M |
| 285 | SEPN | Septerna, Inc. | 1.77B | 0.42% | 266,681 | 98.88M |
| 286 | ALHC | Alignment Healthcare, Inc. | 1.76B | 7.05% | 10,283,466 | 4.58B |
| 287 | BRVE | Braveheart Bio, Inc. | 1.76B | 0.38% | 888,960 | - |
| 288 | PSNL | Personalis, Inc. | 1.75B | 0.74% | 1,702,462 | 69.67M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.74B | -2.60% | 508,949 | 481.07M |
| 290 | NUVB | Nuvation Bio Inc. | 1.74B | -3.70% | 9,965,604 | 169.90M |
| 291 | SGRY | Surgery Partners, Inc. | 1.73B | 0.08% | 1,566,777 | 3.37B |
| 292 | XRAY | DENTSPLY SIRONA Inc. | 1.71B | -1.27% | 5,008,737 | 3.64B |
| 293 | KMTS | Kestra Medical Technologies, Ltd. | 1.69B | 3.32% | 293,640 | 106.73M |
| 294 | ATEC | Alphatec Holdings, Inc. | 1.66B | 6.88% | 2,063,598 | 815.05M |
| 295 | STOK | Stoke Therapeutics, Inc. | 1.63B | -1.17% | 928,392 | 27.59M |
| 296 | CMPS | COMPASS Pathways plc | 1.61B | -2.52% | 3,772,831 | - |
| 297 | OCUL | Ocular Therapeutix, Inc. | 1.59B | 4.17% | 5,620,002 | 52.06M |
| 298 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | 1.31% | 1,459,828 | 252.25M |
| 299 | ETON | Eton Pharmaceuticals, Inc. | 1.59B | 0.47% | 405,458 | 105.60M |
| 300 | QURE | uniQure N.V. | 1.58B | -2.81% | 3,041,928 | 18.67M |
| 301 | OMCL | Omnicell, Inc. | 1.58B | 3.10% | 397,667 | 1.25B |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | 0.55% | 346,867 | 978.38M |
| 303 | RAPP | Rapport Therapeutics, Inc. | 1.54B | 0.06% | 198,868 | 20.00M |
| 304 | NUTX | Nutex Health Inc. | 1.54B | 3.93% | 156,467 | 846.72M |
| 305 | CERT | Certara, Inc. | 1.54B | 7.59% | 2,940,704 | 421.75M |
| 306 | IMCR | Immunocore Holdings plc | 1.52B | -0.40% | 329,451 | 430.78M |
| 307 | GHRS | GH Research PLC | 1.52B | -3.36% | 206,965 | - |
| 308 | PAHC | Phibro Animal Health Corporation | 1.51B | -0.13% | 280,031 | 1.52B |
| 309 | INVA | Innoviva, Inc. | 1.49B | 0.68% | 993,390 | 440.00M |
| 310 | ARDT | Ardent Health, Inc. | 1.49B | 2.03% | 376,735 | 6.41B |
| 311 | ANAB | AnaptysBio, Inc. | 1.47B | 1.38% | 595,547 | 106.09M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.47B | - | 588,015 | 20.00M |
| 313 | TSHA | Taysha Gene Therapies, Inc. | 1.46B | -3.02% | 4,975,354 | 5.49M |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.45B | 1.53% | 764,803 | 1.86B |
| 315 | NKTR | Nektar Therapeutics | 1.44B | -3.12% | 2,029,306 | 54.59M |
| 316 | TYRA | Tyra Biosciences, Inc. | 1.44B | 2.45% | 614,361 | - |
| 317 | COAG | Hemab Therapeutics Holdings, Inc. | 1.43B | -1.67% | 294,545 | - |
| 318 | AMN | AMN Healthcare Services, Inc. | 1.43B | 0.57% | 635,233 | 3.43B |
| 319 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | -4.73% | 4,656,685 | 717.00M |
| 320 | KARD | Kardigan, Inc. | 1.42B | 3.04% | 380,859 | - |
| 321 | CNMD | CONMED Corporation | 1.42B | 2.18% | 343,345 | 1.37B |
| 322 | AGL | agilon health, inc. | 1.42B | 0.17% | 188,130 | 5.92B |
| 323 | PNTG | The Pennant Group, Inc. | 1.41B | 2.70% | 303,917 | 1.10B |
| 324 | KLRA | Kailera Therapeutics, Inc. | 1.41B | 4.33% | 1,811,909 | - |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.40B | 0.67% | 494,758 | - |
| 326 | KRSA | Korsana Biosciences, Inc. | 1.40B | 0.75% | 104,270 | - |
| 327 | INBX | Inhibrx Biosciences, Inc. | 1.39B | -2.51% | 207,091 | 1.30M |
| 328 | DRTS | Alpha Tau Medical Ltd. | 1.37B | 0.81% | 342,443 | - |
| 329 | OMER | Omeros Corporation | 1.37B | 1.56% | 1,068,177 | 38.42M |
| 330 | AAPG | Ascentage Pharma Group International | 1.31B | -4.98% | 3,588 | 94.61M |
| 331 | ORIC | ORIC Pharmaceuticals, Inc. | 1.29B | 2.29% | 1,395,685 | - |
| 332 | OMDA | Omada Health, Inc. | 1.28B | 2.85% | 747,080 | 309.76M |
| 333 | NBTX | Nanobiotix S.A. | 1.27B | -2.52% | 194,238 | 13.15M |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 0.29% | 243,919 | 804.27M |
| 335 | DMRA | Damora Therapeutics, Inc. | 1.25B | -2.08% | 556,057 | - |
| 336 | REPL | Replimune Group, Inc. | 1.24B | 0.61% | 2,275,898 | - |
| 337 | MNKD | MannKind Corporation | 1.23B | 0.53% | 2,876,345 | 393.63M |
| 338 | INNV | InnovAge Holding Corp. | 1.23B | 0.45% | 878,305 | 989.71M |
| 339 | SVRA | Savara Inc. | 1.21B | -0.62% | 2,862,732 | - |
| 340 | CRON | Cronos Group Inc. | 1.20B | 0.78% | 1,217,292 | 179.09M |
| 341 | AVLN | Avalyn Pharma Inc. | 1.20B | -3.91% | 427,272 | - |
| 342 | TRAX | First Tracks Biotherapeutics, Inc. | 1.18B | -0.87% | 667,813 | - |
| 343 | OPK | OPKO Health, Inc. | 1.17B | 0.64% | 1,645,120 | 587.90M |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 0.12% | 1,790,266 | 1.04B |
| 345 | HROW | Harrow, Inc. | 1.15B | 0.33% | 587,352 | 275.59M |
| 346 | GDRX | GoodRx Holdings, Inc. | 1.15B | 2.44% | 882,176 | 785.23M |
| 347 | BCAX | Bicara Therapeutics Inc. | 1.14B | -1.93% | 640,749 | - |
| 348 | BVS | Bioventus Inc. | 1.14B | 2.97% | 357,090 | 581.85M |
| 349 | STAA | STAAR Surgical Company | 1.13B | 0.45% | 471,890 | 339.59M |
| 350 | CSTL | Castle Biosciences, Inc. | 1.12B | 3.07% | 377,255 | 357.28M |
| 351 | LBRX | LB Pharmaceuticals Inc | 1.12B | -6.41% | 494,495 | - |
| 352 | IRMD | IRADIMED CORPORATION | 1.11B | 1.25% | 76,963 | 86.34M |
| 353 | LTGO | Latigo Biotherapeutics, Inc. | 1.10B | 4.59% | 589,999 | - |
| 354 | AORT | Artivion, Inc. | 1.10B | 1.34% | 734,216 | 471.47M |
| 355 | VOR | Vor Biopharma Inc. | 1.10B | -0.59% | 648,600 | - |
| 356 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.08B | -0.24% | 454,522 | 730.02M |
| 357 | ENOV | Enovis Corporation | 1.08B | 5.18% | 1,364,630 | 2.30B |
| 358 | IMTX | Immatics N.V. | 1.06B | 1.84% | 554,120 | 47.65M |
| 359 | TDOC | Teladoc Health, Inc. | 1.05B | 4.89% | 4,471,361 | 2.49B |
| 360 | MGTX | MeiraGTx Holdings plc | 1.05B | 1.20% | 941,654 | 397.50M |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | 4.36% | 616,167 | 1.04B |
| 362 | IART | Integra LifeSciences Holdings Corporation | 1.03B | 4.81% | 1,859,001 | 1.65B |
| 363 | CGEM | Cullinan Therapeutics, Inc. | 1.03B | 3.42% | 1,082,966 | - |
| 364 | AKTS | Aktis Oncology, Inc. | 1.03B | - | 282,981 | 10.06M |
| 365 | PRCT | PROCEPT BioRobotics Corporation | 1.02B | 3.85% | 970,965 | 337.34M |
| 366 | JANX | Janux Therapeutics, Inc. | 1.01B | -2.30% | 533,741 | 24.00M |
| 367 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.01B | 21.30% | 7,690,855 | 132.42M |
| 368 | ODTX | Odyssey Therapeutics, Inc. | 998.62M | 0.53% | 171,782 | 99.00K |
| 369 | PCRX | Pacira BioSciences, Inc. | 998.54M | -0.63% | 560,252 | 746.16M |
| 370 | BBNX | Beta Bionics, Inc. | 997.56M | -0.05% | 624,629 | 119.01M |
| 371 | AHG | Akso Health Group | 993.78M | 0.87% | 29,230 | 13.83M |
| 372 | SPTX | Seaport Therapeutics, Inc. | 990.32M | 0.43% | 172,571 | - |
| 373 | ANL | Adlai Nortye Group Ltd. | 968.54M | -0.33% | 460,576 | 18.06M |
| 374 | MLTX | MoonLake Immunotherapeutics | 968.51M | -0.26% | 1,867,254 | - |
| 375 | HSTM | HealthStream, Inc. | 964.99M | 2.34% | 201,300 | 321.12M |
| 376 | CBLL | CeriBell, Inc. | 954.08M | 4.94% | 239,505 | 101.96M |
| 377 | KURA | Kura Oncology, Inc. | 944.76M | -0.28% | 1,294,991 | 77.23M |
| 378 | ANRO | Alto Neuroscience, Inc. | 942.20M | -3.19% | 550,294 | - |
| 379 | ABUS | Arbutus Biopharma Corporation | 923.95M | 4.94% | 6,183,039 | 181.72M |
| 380 | SLBT | SL Science Holding Limited | 906.72M | 1.27% | 80,867 | 3.27M |
| 381 | APMD | Apnimed, Inc. | 905.47M | 1.12% | 340,303 | 115.12M |
| 382 | CRVS | Corvus Pharmaceuticals, Inc. | 903.46M | -1.47% | 825,385 | - |
| 383 | JBIO | Jade Biosciences, Inc. | 894.82M | -0.35% | 607,057 | - |
| 384 | RIGL | Rigel Pharmaceuticals, Inc. | 892.71M | 1.36% | 391,628 | 276.79M |
| 385 | PACB | Pacific Biosciences of California, Inc. | 892.08M | 12.99% | 26,246,979 | 159.27M |
| 386 | SIBN | SI-BONE, Inc. | 887.86M | 9.57% | 632,024 | 213.60M |
| 387 | ALMS | Alumis Inc. | 885.34M | -0.15% | 3,871,900 | 7.40M |
| 388 | GLUE | Monte Rosa Therapeutics, Inc. | 876.17M | -2.19% | 1,749,263 | 28.73M |
| 389 | SANA | Sana Biotechnology, Inc. | 862.16M | -0.35% | 5,394,074 | - |
| 390 | SGP | SpyGlass Pharma, Inc. | 855.93M | 2.69% | 133,105 | - |
| 391 | OBX | Obsidian Therapeutics, Inc. | 854.94M | 1.84% | 199,186 | - |
| 392 | ARDX | Ardelyx, Inc. | 844.75M | 1.50% | 4,253,036 | 450.89M |
| 393 | IMMX | Immix Biopharma, Inc. | 839.81M | 4.65% | 1,597,501 | - |
| 394 | HELP | Helus Pharma Inc. | 834.35M | -2.39% | 1,325,305 | - |
| 395 | QDEL | QuidelOrtho Corporation | 832.51M | 12.72% | 2,693,172 | 2.67B |
| 396 | ATTO | Attovia Therapeutics, Inc. | 821.49M | 4.80% | 455,959 | 1.80M |
| 397 | INMD | InMode Ltd. | 812.20M | 0.28% | 497,748 | 374.63M |
| 398 | IVA | Inventiva S.A. | 797.22M | -2.25% | 1,701,580 | 2.81M |
| 399 | ANNX | Annexon, Inc. | 796.23M | 0.24% | 3,448,838 | - |
| 400 | CTKB | Cytek Biosciences, Inc. | 791.60M | 3.75% | 1,788,139 | 206.71M |
| 401 | AVTX | Avalo Therapeutics, Inc. | 783.00M | -2.60% | 736,839 | 59.00K |
| 402 | CADL | Candel Therapeutics, Inc. | 782.78M | 0.49% | 980,886 | - |
| 403 | GYRE | Gyre Therapeutics, Inc. | 779.35M | 3.38% | 181,458 | 109.82M |
| 404 | VREX | Varex Imaging Corporation | 777.63M | -0.05% | 298,071 | 865.00M |
| 405 | GERN | Geron Corporation | 777.39M | 0.83% | 6,366,748 | 204.56M |
| 406 | DSGN | Design Therapeutics, Inc. | 777.26M | 0.65% | 680,775 | - |
| 407 | GMRS | GMR Solutions Inc. | 775.66M | 0.91% | 435,960 | 5.88B |
| 408 | LXRX | Lexicon Pharmaceuticals, Inc. | 774.22M | -4.40% | 2,716,386 | 41.47M |
| 409 | AHCO | AdaptHealth Corp. | 765.77M | 2.50% | 3,264,127 | 3.36B |
| 410 | SLDB | Solid Biosciences Inc. | 757.01M | 3.07% | 1,372,173 | - |
| 411 | WVE | Wave Life Sciences, Inc. | 738.93M | -0.79% | 3,514,892 | 65.37M |
| 412 | AVR | Anteris Technologies Global Corp. | 736.08M | -2.08% | 1,892,812 | 2.24M |
| 413 | VSTM | Verastem, Inc. | 724.51M | 3.90% | 2,217,136 | 87.53M |
| 414 | OLMA | Olema Pharmaceuticals, Inc. | 721.86M | 0.24% | 1,006,119 | - |
| 415 | ACHV | Achieve Life Sciences, Inc. | 721.35M | -3.18% | 1,704,574 | - |
| 416 | OABI | OmniAb, Inc. | 715.32M | 1.03% | 1,216,108 | 38.46M |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 713.76M | -5.49% | 2,110,579 | 92.01M |
| 418 | COLL | Collegium Pharmaceutical, Inc. | 711.99M | -0.68% | 975,381 | 808.21M |
| 419 | FTH | Faeth Therapeutics, Inc. | 700.28M | -4.41% | 412,835 | - |
| 420 | SOPH | SOPHiA GENETICS SA | 698.05M | 1.61% | 1,181,659 | 86.17M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 696.92M | -2.42% | 194,271 | - |
| 422 | PHAR | Pharming Group N.V. | 693.58M | 0.51% | 10,814 | 366.48M |
| 423 | MDXG | MiMedx Group, Inc. | 663.21M | -0.87% | 894,726 | 355.17M |
| 424 | STTK | Shattuck Labs, Inc. | 652.36M | -3.42% | 1,239,353 | 1.00M |
| 425 | AURA | Aura Biosciences, Inc. | 645.04M | 2.13% | 589,814 | - |
| 426 | PHR | Phreesia, Inc. | 643.68M | 2.98% | 504,070 | 507.79M |
| 427 | ANGO | AngioDynamics, Inc. | 642.31M | 2.85% | 636,168 | 320.17M |
| 428 | STLN | Starling Oncology, Inc. | 642.07M | -0.79% | 1,336,776 | 587.24M |
| 429 | SGMT | Sagimet Biosciences Inc. | 640.31M | -1.20% | 1,528,740 | - |
| 430 | ZVRA | Zevra Therapeutics, Inc. | 635.41M | 7.11% | 1,977,765 | 136.07M |
| 431 | CLYM | Climb Bio, Inc. | 634.67M | 1.01% | 1,206,413 | - |
| 432 | BLSM | BlossomHill Therapeutics, Inc. | 633.79M | 1.27% | 201,550 | - |
| 433 | ACRS | Aclaris Therapeutics, Inc. | 628.54M | -2.73% | 7,015,491 | 8.22M |
| 434 | FLGT | Fulgent Genetics, Inc. | 617.72M | 4.52% | 307,982 | 323.93M |
| 435 | DBVT | DBV Technologies S.A. | 615.65M | -1.04% | 224,452 | 5.04M |
| 436 | ETRA | Electra Therapeutics, Inc. | 611.35M | -6.08% | 334,447 | - |
| 437 | SLN | Silence Therapeutics plc | 610.52M | -4.70% | 976,297 | 615.00K |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 603.13M | 0.27% | 2,227,097 | 389.32M |
| 439 | KIDS | OrthoPediatrics Corp. | 597.65M | 3.29% | 304,773 | 252.72M |
| 440 | CBIO | Crescent Biopharma, Inc. | 596.65M | -2.65% | 187,006 | 11.88M |
| 441 | EVO | Evotec SE | 590.17M | 3.75% | 341,976 | 819.47M |
| 442 | WEAV | Weave Communications, Inc. | 588.79M | -0.14% | 786,948 | 257.79M |
| 443 | AQST | Aquestive Therapeutics, Inc. | 573.59M | 0.44% | 1,092,970 | 54.09M |
| 444 | PRME | Prime Medicine, Inc. | 571.07M | 7.72% | 4,716,863 | 4.07M |
| 445 | CRMD | CorMedix Inc. | 565.88M | 0.97% | 1,257,332 | 462.25M |
| 446 | CTMX | CytomX Therapeutics, Inc. | 562.18M | 0.78% | 1,767,319 | 18.30M |
| 447 | SSII | SS Innovations International, Inc. | 555.07M | 3.75% | 51,322 | 52.40M |
| 448 | DCTH | Delcath Systems, Inc. | 550.67M | 4.89% | 427,999 | 95.42M |
| 449 | SENS | Senseonics Holdings, Inc. | 545.13M | 4.35% | 709,560 | 48.55M |
| 450 | VALN | Valneva SE | 542.73M | 1.31% | 69,379 | 163.30M |
| 451 | PHAT | Phathom Pharmaceuticals, Inc. | 532.18M | -3.18% | 1,104,735 | 239.66M |
| 452 | NGNE | Neurogene Inc. | 529.70M | 3.20% | 211,774 | 925.00K |
| 453 | MASS | 908 Devices Inc. | 529.07M | 0.87% | 419,453 | 60.84M |
| 454 | OCS | Oculis Holding AG | 528.43M | -1.95% | 242,001 | 1.45M |
| 455 | MNPR | Monopar Therapeutics Inc. | 525.50M | 0.41% | 128,262 | - |
| 456 | ALT | Altimmune, Inc. | 519.36M | -2.38% | 3,839,540 | 31.00K |
| 457 | ALLO | Allogene Therapeutics, Inc. | 518.24M | - | 4,443,266 | 4.64M |
| 458 | MPLT | MapLight Therapeutics, Inc. | 515.46M | -5.55% | 262,133 | - |
| 459 | RGNX | REGENXBIO Inc. | 512.26M | 4.44% | 2,353,594 | 174.48M |
| 460 | TLRY | Tilray Brands, Inc. | 509.61M | 3.05% | 4,367,159 | 915.45M |
| 461 | TCMD | Tactile Systems Technology, Inc. | 509.00M | 1.67% | 352,808 | 350.31M |
| 462 | EPRX | Eupraxia Pharmaceuticals Inc. | 508.52M | 6.98% | 1,774,895 | - |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 464 | GLAS | Glass House Brands Inc. | 504.20M | -2.55% | 1,170,848 | 176.98M |
| 465 | YDES | YD Bio Limited | 503.61M | -12.33% | 258,509 | 1.24M |
| 466 | DRUG | Bright Minds Biosciences Inc. | 502.29M | -1.78% | 55,951 | - |
| 467 | PBYI | Puma Biotechnology, Inc. | 499.17M | 1.68% | 297,628 | 231.24M |
| 468 | EOLS | Evolus, Inc. | 493.40M | 4.62% | 786,428 | 316.49M |
| 469 | SGHT | Sight Sciences, Inc. | 491.38M | 4.57% | 564,941 | 83.38M |
| 470 | BWAY | BrainsWay Ltd. | 488.36M | -2.16% | 231,205 | 60.70M |
| 471 | ARVN | Arvinas, Inc. | 487.78M | 0.67% | 628,531 | 316.70M |
| 472 | AUTL | Autolus Therapeutics plc | 487.08M | 2.81% | 2,521,524 | 117.39M |
| 473 | TKNO | Alpha Teknova, Inc. | 483.19M | 0.11% | 480,126 | 43.70M |
| 474 | CTNM | Contineum Therapeutics, Inc. | 478.54M | -3.05% | 508,398 | - |
| 475 | PROK | ProKidney Corp. | 477.67M | -8.14% | 985,936 | 818.00K |
| 476 | ITOC | iTonic Holdings Ltd. | 474.94M | 1.85% | 12,932 | 556.43K |
| 477 | CERS | Cerus Corporation | 471.57M | 2.63% | 1,843,113 | 221.55M |
| 478 | ASMB | Assembly Biosciences, Inc. | 463.00M | 0.89% | 241,748 | 74.85M |
| 479 | NRC | NRC Health | 459.64M | 2.11% | 117,690 | 140.00M |
| 480 | KMDA | Kamada Ltd. | 457.91M | -3.73% | 137,513 | 191.85M |
| 481 | OVID | Ovid Therapeutics Inc. | 457.00M | -1.68% | 1,200,104 | 1.58M |
| 482 | RZLT | Rezolute, Inc. | 454.20M | 7.98% | 4,197,536 | - |
| 483 | DMAC | DiaMedica Therapeutics Inc. | 454.05M | 2.31% | 231,379 | - |
| 484 | NPCE | NeuroPace, Inc. | 453.77M | 4.09% | 149,434 | 106.99M |
| 485 | ENTX | Entera Bio Ltd. | 453.63M | -8.39% | 1,254,986 | 42.00K |
| 486 | CAPR | Capricor Therapeutics, Inc. | 452.32M | -13.07% | 6,771,863 | 11.13M |
| 487 | TECX | Tectonic Therapeutic, Inc. | 451.79M | 2.53% | 312,646 | - |
| 488 | MYGN | Myriad Genetics, Inc. | 438.08M | 0.88% | 2,759,838 | 806.60M |
| 489 | EDIT | Editas Medicine, Inc. | 428.49M | 6.49% | 3,019,176 | 47.01M |
| 490 | AGMB | AgomAb Therapeutics NV | 427.96M | 1.52% | 129,804 | - |
| 491 | SPRY | ARS Pharmaceuticals, Inc. | 426.63M | 5.41% | 1,621,611 | 116.93M |
| 492 | SRTA | Strata Critical Medical, Inc. | 425.53M | 1.69% | 1,160,878 | 255.98M |
| 493 | PRTA | Prothena Corporation plc | 424.56M | -1.08% | 714,463 | 54.53M |
| 494 | CTEV | Claritev Corporation | 418.26M | 4.05% | 223,325 | 994.67M |
| 495 | CARL | Carlsmed, Inc. | 417.73M | 7.22% | 130,639 | 63.30M |
| 496 | ARCT | Arcturus Therapeutics Holdings Inc. | 416.68M | 12.51% | 1,316,537 | 29.37M |
| 497 | AVIR | Atea Pharmaceuticals, Inc. | 411.45M | - | 293,607 | - |
| 498 | RCEL | AVITA Medical, Inc. | 409.78M | 4.17% | 420,757 | 75.63M |
| 499 | EIKN | Eikon Therapeutics, Inc. | 408.40M | 2.86% | 485,357 | - |
| 500 | EVH | Evolent Health, Inc. | 408.14M | 4.34% | 1,341,865 | 2.10B |